2017
DOI: 10.1016/j.clnesp.2017.01.005
View full text
|
|
Share
Patricia Quadros dos Santos, Jorge C. Guedes, Rosangela P. de Jesus, Raquel Rocha dos Santos, Rosemeiri L. Fiaconne

Abstract: The use of symbiotics improved the clinical and laboratory profiles of the evaluated patients with CP, favoring the best clinical outcome, and may be a therapeutic option because of the low cost and therapeutic effectiveness in this population.